Kristine Engelke

All filings by Kristine Engelke on record concern Questcor Pharmaceuticals Inc. The record holds 5 filings, for trades running from 9 August 2011 to 2 September 2011.

In open-market terms, that means 1 purchase worth €1,043 on one side and 3 sales worth €97k on the other. Taken together, the sales exceed the purchases by €96k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 1 option exercise.

The latest filing, published on 6 September 2011, reports an open-market sale of €5,313 in Questcor Pharmaceuticals Inc. The most recent open-market purchase was published on 18 August 2011, 5,562 days ago. The median gap between a trade and its publication by SEC (Form 4) is 4 days. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.